Gainers

• Mustang Bio (NASDAQ:MBIO) shares moved upwards by 19.4% to $0.8 during Friday's after-market session. The company's market cap stands at $5.2 million.
• Context Therapeutics (NASDAQ:CNTX) stock increased by 14.28% to $2.0. The market value of their outstanding shares is at $186.5 million.
• Insight Molecular (NASDAQ:IMDX) stock rose 13.16% to $5.93. The market value of their outstanding shares is at $211.5 million.
• Bio Green Med Solution (NASDAQ:BGMS) shares moved upwards by 11.99% to $1.68. The market value of their outstanding shares is at $5.8 million.
• Shattuck Labs (NASDAQ:STTK) shares increased by 10.69% to $5.07. The company's market cap stands at $368.0 million.
• Aldeyra Therapeutics (NASDAQ:ALDX) stock rose 7.97% to $1.76. The market value of their outstanding shares is at $106.1 million.

Losers

• Inotiv (NASDAQ:NOTV) shares fell 15.8% to $0.14 during Friday's after-market session. The market value of their outstanding shares is at $2.9 million.
• Entrada Therapeutics (NASDAQ:TRDA) shares fell 13.66% to $5.5. The company's market cap stands at $271.7 million.
• Basel Medical Group (NASDAQ:BMGL) stock declined by 12.13% to $0.48. The market value of their outstanding shares is at $9.1 million.
• ALPS Group (NASDAQ:ALPS) shares declined by 11.27% to $0.63. The market value of their outstanding shares is at $116.5 million.
• Clearmind Medicine (NASDAQ:CMND) shares decreased by 9.8% to $3.59. The company's market cap stands at $2.9 million.
• Indaptus Therapeutics (NASDAQ:INDP) shares fell 7.66% to $3.38. The market value of their outstanding shares is at $537.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.